Life at the Johns Hopkins School of Medicine
Much of the general public believes oncology is a “sad” field. Amol Narang, and many other practicing oncologists, disagree. Learn about his inspiring profession and why he would choose to be an oncologist time and time again.
Epigenetic drugs are an emerging class of cancer therapeutics. In this article, Ph.D. candidate Roshan Chikarmane introduces Foghorn Therapeutics, its co-founder, Cigall Kadoch, and the science behind their drug development program.
Next generation cancer diagnostics are poised to change the way that cancer is detected and treated. Ph.D. candidate Roshan Chikarmane shares his perspectives on the teams and technologies that are leading the charge.
Health care has pivoted in response to COVID-19, but how have these changes affected cancer patients? A student shares her perspective on having a parent with cancer during the pandemic.
Pulitzer Prize-winning author and oncologist Siddhartha Mukherjee along with former executive vice president of the American Cancer Society and Hopkins oncologist Otis Brawley spoke with the Washington Post about how COVID-19 affects cancer outcomes.
The Longrifles Cancer Seminar series, founded by Don Coffey, remains a hub of collaborative brainstorming for the Brady Urological Institute.
The benefits of detecting and treating cancer at early developmental stages have long been observed by clinical oncologists. Colonoscopies as well as other methods for… Read More »Cancer Diagnosis — It’s in Your Blood
It has long been known — thanks largely to work by Johns Hopkins’ own Bert Vogelstein — that cancer is a disease generally caused by… Read More »Cancer and the Mutation Paradox
In a 1909 manuscript titled “Ueber den jetzigen Stand der Chemotherapie” (“About the Current State of Chemotherapy”), Nobel laureate Paul Ehrlich proclaimed, “We must learn… Read More »Engineering Magic Bullets for Pancreatic Cancer
Melanoma cells stained with PTRF (in red), RPA194 (in green) and nucleus stained in blue. RPA194 is the main subunit of the RNA polymerase I… Read More »The Colorful World of Cancer Drug Discovery